Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
28.39
-0.37 (-1.29%)
Oct 30, 2026, 4:00 PM EST - Market closed
Zenas BioPharma Market Cap
Zenas BioPharma has a market cap or net worth of $1.85 billion as of October 30, 2026. It is the 6,838th most valuable company in the world and the 1,826th biggest in the United States. Its market cap has increased by 23.42% in one year.
Market Cap
1.85B
Enterprise Value
1.51B
1-Year Change
23.42%
Global Rank
Country Rank
#1,826 United States
Category
ChartMarket Cap Chart
Since the IPO on September 13, 2024, Zenas BioPharma's market cap has increased from $676.47M to $1.85B, an increase of 173.53%. That is a compound annual growth rate of 60.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 1.85B | -5.07% |
| Dec 31, 2025 | 1.95B | 469.46% |
| Dec 31, 2024 | 342.27M | -49.40% |
| Sep 13, 2024 | 676.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SELLAS Life Sciences Group | 1.95B |
| Hemab Therapeutics Holdings | 1.94B |
| Trevi Therapeutics | 1.93B |
| Vir Biotechnology | 1.91B |
| Absci | 1.91B |
| ADARx Pharmaceuticals | 1.90B |
| First Tracks Biotherapeutics | 1.89B |
| Generate Biomedicines | 1.86B |